Search research articles
Contact Us
Filters
Showing results (41-50 of 469) with videos related to
Page
of 47
Sort By:
Endocrine
|
May 17, 2017
Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals
Yoshitaka Hashimoto, Masahide Hamaguchi, Takuya Fukuda, et al.
BMC Endocrine Disorders
|
July 26, 2020
Triglyceride-glucose index (TyG index) is a predictor of incident colorectal cancer: a population-based longitudinal study
Takuro Okamura, Yoshitaka Hashimoto, Masahide Hamaguchi, et al.
Diabetes Care
|
November 25, 2004
Association between urinary albumin excretion and serum dehydroepiandrosterone sulfate concentration in male patients with type 2 diabetes: a possible link between urinary albumin excretion and cardiovascular disease
Michiaki Fukui, Yoshihiro Kitagawa, Naoto Nakamura, et al.
BMJ Open Diabetes Research & Care
|
September 9, 2020
Effect of alcohol consumption and the presence of fatty liver on the risk for incident type 2 diabetes: a population-based longitudinal study
Takuro Okamura, Yoshitaka Hashimoto, Masahide Hamaguchi, et al.
Journal of Diabetes Investigation
|
November 18, 2020
Association of mean corpuscular volume with sarcopenia and visceral obesity in individuals without anemia
Muhei Tanaka, Hiroshi Okada, Yoshitaka Hashimoto, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
December 10, 2020
Distinct associations of intraperitoneal and retroperitoneal visceral adipose tissues with metabolic syndrome and its components
Muhei Tanaka, Hiroshi Okada, Yoshitaka Hashimoto, et al.
Journal of Clinical Biochemistry and Nutrition
|
August 6, 2019
The sodium-glucose cotransporter 2 inhibitor luseogliflozin can suppress muscle atrophy in Db/Db mice by suppressing the expression of <i>foxo1</i>
Takuro Okamura, Yoshitaka Hashimoto, Takafumi Osaka, et al.
Metabolism: Clinical and Experimental
|
January 15, 2008
Association between serum estradiol concentrations and carotid atherosclerosis in men with type 2 diabetes mellitus
Michiaki Fukui, Yoshihiro Kitagawa, Kenji Kamiuchi, et al.
BMJ Open Ophthalmology
|
August 21, 2018
The Efficacy of Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors for the treatment of chronic diabetic macular oedema in vitrectomised eyes: a retrospective study
Hiroki Mieno, Kazuhito Yoneda, Masahiro Yamazaki, et al.
Plos One
|
January 11, 2024
Protocol of efficacy of bifidobacteria intake on gastrointestinal symptoms in symptomatic type 2 diabetes mellitus patients in abdominis: An open-label, randomized controlled trial (Binary STAR study)
Yoshitaka Hashimoto, Genki Kobayashi, Noriyuki Kitagawa, et al.
Page
of 47
Search research articles
Search
Showing results (41-50 of 469) with videos related to
Sort By:
Page
of 47
Endocrine
|
May 17, 2017
Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals
Yoshitaka Hashimoto, Masahide Hamaguchi, Takuya Fukuda, et al.
BMC Endocrine Disorders
|
July 26, 2020
Triglyceride-glucose index (TyG index) is a predictor of incident colorectal cancer: a population-based longitudinal study
Takuro Okamura, Yoshitaka Hashimoto, Masahide Hamaguchi, et al.
Diabetes Care
|
November 25, 2004
Association between urinary albumin excretion and serum dehydroepiandrosterone sulfate concentration in male patients with type 2 diabetes: a possible link between urinary albumin excretion and cardiovascular disease
Michiaki Fukui, Yoshihiro Kitagawa, Naoto Nakamura, et al.
BMJ Open Diabetes Research & Care
|
September 9, 2020
Effect of alcohol consumption and the presence of fatty liver on the risk for incident type 2 diabetes: a population-based longitudinal study
Takuro Okamura, Yoshitaka Hashimoto, Masahide Hamaguchi, et al.
Journal of Diabetes Investigation
|
November 18, 2020
Association of mean corpuscular volume with sarcopenia and visceral obesity in individuals without anemia
Muhei Tanaka, Hiroshi Okada, Yoshitaka Hashimoto, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
December 10, 2020
Distinct associations of intraperitoneal and retroperitoneal visceral adipose tissues with metabolic syndrome and its components
Muhei Tanaka, Hiroshi Okada, Yoshitaka Hashimoto, et al.
Journal of Clinical Biochemistry and Nutrition
|
August 6, 2019
The sodium-glucose cotransporter 2 inhibitor luseogliflozin can suppress muscle atrophy in Db/Db mice by suppressing the expression of <i>foxo1</i>
Takuro Okamura, Yoshitaka Hashimoto, Takafumi Osaka, et al.
Metabolism: Clinical and Experimental
|
January 15, 2008
Association between serum estradiol concentrations and carotid atherosclerosis in men with type 2 diabetes mellitus
Michiaki Fukui, Yoshihiro Kitagawa, Kenji Kamiuchi, et al.
BMJ Open Ophthalmology
|
August 21, 2018
The Efficacy of Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors for the treatment of chronic diabetic macular oedema in vitrectomised eyes: a retrospective study
Hiroki Mieno, Kazuhito Yoneda, Masahiro Yamazaki, et al.
Plos One
|
January 11, 2024
Protocol of efficacy of bifidobacteria intake on gastrointestinal symptoms in symptomatic type 2 diabetes mellitus patients in abdominis: An open-label, randomized controlled trial (Binary STAR study)
Yoshitaka Hashimoto, Genki Kobayashi, Noriyuki Kitagawa, et al.
Page
of 47